Primære forskningsområder

Born: July 1, 1958 in Arlington, VA, USA,

1985       MD – Faculty of Health Sciences, University of Copenhagen.

2003       Specialist in cardiac surgery, Danish National Board of Health 

2013       Emergency Medicine Diploma, Organization of Danish Medical Societies 

2018       Specialist in emergency medicine, Danish Patient Safety Authority 

2024 Clinical professor, Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark and The Emergency Department, North Zealand Hospital, Denmark

Doctoral Thesis : Human myocardial and skeletal muscular Na,K-ATPase in relation to digoxin therapy of heart failure was defended orally September 12, 1997. Faculty of Health Sciences, University of Copenhagen

Academid award and honors: Young Investigator Award at the 4th International Symposium on Cardiovascular Pharmacology, Geneva, Switzerland, April 1991.

Teaching award The Order of St John of God (Fatebenefratelli), Rome, Italy, November 2004

Young Investigator Award (senior author) at the 5^th Danish Society for Emergency Medicine Conference. Århus, Denmark, April 2013

Young Investigator Award (senior author) at the 10^th European Society of Emergency Medicine, Vienna, Austria, October 2016

Best Abstracts Award (senior author) at the 11^th European Society of Emergency Medicine, Glasgow, Scotland, October 2018

Fellow of the European Society of Cardiology (FESC), August 2018

Department most improved in medical tuition award (dk: Årets højdespringer) Danish Health Authority, 2023

Management experience: 01.08.05 – 31.10.08 Novo Nordisk: Medically responsible for development of rFVIIa in cardiac surgery F7CARD-1610 trial with a budget of DKK 55 M.

01.08.14 – 30.04.19 Head of Research (dk: forskningschef, leder af Forskningens Hus), the Research Facility, Holbaek Hospital, Copenhagen University Hospital, Denmark

Scientific focus areas: Multimorbidity and challenges in emergency medicine, T2DM, clinical trials, Na,K-ATPase quantification, K-handling, digoxin treatment

Board memberships: Elected member of the Board of the Organization of Danish Medical Societies (dk: Organisationen af Lægevidenskabelige Selskaber (LVS), November 2014, November 2016 and November 2018 (Resigned 2020)

Elected member of the Nucleus of the Working Group for Cardiovascular Pharmacotherapy, European Society of Cardiology, August 2016 - 2020

Elected treasurer Nucleus of the Working Group for Cardiovascular Pharmacotherapy, European Society of Cardiology, August 2018 – 2020

Invited member of the European Society of Cardiology Regulatory Affairs Committee for the term 2020-2022

Official opponent PhDs and doctoral theses: University for Southern Denmark (3) and Medical University of Vienna, Austria (1)

Recent commision as Invited Speaker: Update om metabolic syndrome. Pharmacy meets cardiovascular pharmacotherapy March 2024. Diabetes mellitus. Paracelsus Medizinische Universität, Salzburg, Austria